Building Biotech to Last [Entire Talk]

Dr. Trevor Martin is the CEO and co-founder of Mammoth Biosciences, which addresses challenges across healthcare, agriculture, environmental monitoring, biodefense, and more through discovery of novel CRISPR systems to power the next generation of CRISPR-based synthetic biology products. Ursheet Parikh is a partner at the venture capital firm Mayfield, where he co-leads the Human and Planetary Health investment practice, which includes an investment in Mammoth. In this conversation with Stanford adjunct lecturer Ravi Belani, Martin and Parikh share their advice for building a platform biotech company with staying power.

------------------------

Stanford eCorner content is produced by the Stanford Technology Ventures Program. At STVP, we empower aspiring entrepreneurs to become global citizens who create and scale responsible innovations.

CONNECT WITH US
Twitter: https://twitter.com/ECorner
LinkedIn: https://www.linkedin.com/company/stan...
Facebook: https://www.facebook.com/StanfordTech...

LISTEN
Apple: https://podcasts.apple.com/us/podcast...
Spotify: https://open.spotify.com/show/24QifPS...

LEARN MORE
eCorner Website: https://ecorner.stanford.edu/
STVP Website: https://stvp.stanford.edu/

Support our mission of providing students and educators around the world with free access to Stanford University's network of entrepreneurial thought leaders: https://ecorner.stanford.edu/give.

Видео Building Biotech to Last [Entire Talk] канала Stanford eCorner